Author:
Arina Ainhoa,Corrales Leticia,Bronte Vincenzo
Funder
FIRB
AIRC
Ludwig Foundation
Cancer Research Institute Irvington
Subject
Immunology,Immunology and Allergy
Reference137 articles.
1. Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates;Brahmer;J. Clin. Oncol.,2010
2. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer;Brahmer;N. Engl. J. Med.,2012
3. Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma;Hamid;N. Engl. J. Med.,2013
4. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer;Topalian;N. Engl. J. Med.,2012
5. Adoptive T cell transfer for cancer immunotherapy in the era of synthetic biology;Kalos;Immunity,2013
Cited by
46 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献